Biocon to Launch ₹4,500 Crore QIP to Strengthen Balance Sheet; Kotak, Goldman Sachs, BofA Onboarded as Advisors
Global biopharmaceutical major Biocon Ltd, led by Kiran Mazumdar-Shaw, is set to launch a Qualified Institutional Placement (QIP) worth up to ₹4,500 crore, possibly as early as this week, according to multiple reports. The capital raise is aimed at reducing the company’s ₹1.2 billion net debt and bolstering its financial health. Top Investment Banks Advising…
